The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
Abstract
Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2000.18.20.3558 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 11032599 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines Howard OzerxHoward OzerSearch for articles by this author , James O. ArmitagexJames O. ArmitageSearch for articles by this author , Charles L. BennettxCharles L. BennettSearch for articles by this author , Jeffrey CrawfordxJeffrey CrawfordSearch for articles by this author , George D. DemetrixGeorge D. DemetriSearch for articles by this author , Philip A. PizzoxPhilip A. PizzoSearch for articles by this author , Charles A. SchifferxCharles A. SchifferSearch for articles by this author , Thomas J. SmithxThomas J. SmithSearch for articles by this author , George SomloxGeorge SomloSearch for articles by this author , James C. WadexJames C. WadeSearch for articles by this author , James L. Wade IIIxJames L. Wade IIISearch for articles by this author , Rodger J. WinnxRodger J. WinnSearch for articles by this author , Antoinette J. WozniakxAntoinette J. WozniakSearch for articles by this author , Mark R. SomerfieldxMark R. SomerfieldSearch for articles by this author , for the American Society of Clinical Oncology Growth Factors Expert PanelxSearch for articles by this author Show More From the American Society of Clinical Oncology. https://doi.org/10.1200/JCO.2000.18.20.3558 First Page Full Text PDF Figures and Tables © 2000 by American Society of Clinical Oncology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., & Miller, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304083281404 · Cited by 2,149
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., Grous, J., Picozzi, V., Rausch, G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250305 · Cited by 1,390
Self-citationCunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Canellos, G. P., Anderson, J. R., Propert, K. J., Nissen, N., Cooper, M. R., Henderson, E. S., Green, M. R., Gottlieb, A., & Peterson, B. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272102 · Cited by 1,148
Loehrer, P. J., Einhorn, L. H., Elson, P. J., Crawford, E. D., Kuebler, P., Tannock, I., Raghavan, D., Stuart-Harris, R., Sarosdy, M. F., & Lowe, B. A. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1066 · Cited by 981
von Pawel, J., Schiller, J. H., Shepherd, F. A., Fields, S. Z., Kleisbauer, J. P., Chrysson, N. G., Stewart, D. J., Clark, P. I., Palmer, M. C., Depierre, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.658 · Cited by 968
Gabrilove, J. L., Jakubowski, A., Scher, H., Sternberg, C., Wong, G., Grous, J., Yagoda, A., Fain, K., Moore, M. A. S., Clarkson, B., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806023182202 · Cited by 938
Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia
Wood, A. J. J., & Pizzo, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281808 · Cited by 838
Self-citationForastiere, A. A., Metch, B., Schuller, D. E., Ensley, J. F., Hutchins, L. F., Triozzi, P., Kish, J. A., McClure, S., VonFeldt, E., & Williamson, S. K. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1245 · Cited by 752
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
Self-citationEffective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Barlogie, B., Smith, L., & Alexanian, R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405243102104 · Cited by 641
Vadhan-Raj, S., Keating, M., LeMaistre, A., Hittelman, W. N., McCredie, K., Trujillo, J. M., Broxmeyer, H. E., Henney, C., & Gutterman, J. U. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172501 · Cited by 624
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Schmitz, N., Dreger, P., Linch, D. C., Goldstone, A. H., Boogaerts, M. A., Demuynck, H. M. S., Ferrant, A., Zander, A., Link, H., Barge, A., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90536-x · Cited by 610
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
Roth, B. J., Johnson, D. H., Einhorn, L. H., Schacter, L. P., Cherng, N. C., Cohen, H. J., Crawford, J., Randolph, J. A., Goodlow, J. L., & Broun, G. O. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.282 · Cited by 556
Self-citationDose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
Wozniak, A. J., Crowley, J. J., Balcerzak, S. P., Weiss, G. R., Spiridonidis, C. H., Baker, L. H., Albain, K. S., Kelly, K., Taylor, S. A., Gandara, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2459 · Cited by 555
Self-citationGianni, L., Munzone, E., Capri, G., Fulfaro, F., Tarenzi, E., Villani, F., Spreafico, C., Laffranchi, A., Caraceni, A., & Martini, C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2688 · Cited by 553
Talcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Antman, K. H., Crowley, J. J., Balcerzak, S. P., Rivkin, S. E., Weiss, G. R., ELIAS, A. D., Natale, R. B., Cooper, R. M., Barlogie, B., & Trump, D. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1276 · Cited by 478
Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E., Haferlach, T., Löffler, H., Hunter, A., & Russell, N. H. (1995) · Blood · doi:10.1182/blood.v85.6.1666.bloodjournal8561666 · Cited by 474
Stadtmauer, E. A., O'Neill, A., Goldstein, L. J., Crilley, P. A., Mangan, K. F., Ingle, J. N., Brodsky, I., Martino, S., Lazarus, H. M., Erban, J. K., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421501 · Cited by 460
Stone, R. M., Berg, D. T., George, S. L., Dodge, R. K., Paciucci, P. A., Schulman, P., Lee, E. J., Moore, J. O., Powell, B. L., & Schiffer, C. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322503 · Cited by 447
Self-citationRowe, J., Andersen, J., Mazza, J., Bennett, J., Paietta, E., Hayes, F., Oette, D., Cassileth, P., Stadtmauer, E., & Wiernik, P. (1995) · Blood · doi:10.1182/blood.v86.2.457.bloodjournal862457 · Cited by 443
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 442
(1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2471 · Cited by 436
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Nabholtz, J. M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P., Klaassen, U., Namer, M., Bonneterre, J., Fumoleau, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1858 · Cited by 380
Poon, M. A., O'Connell, M. J., Wieand, H. S., Krook, J. E., Gerstner, J. B., Tschetter, L. K., Levitt, R., Kardinal, C. G., & Mailliard, J. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.11.1967 · Cited by 375
Kaplan, L. D., Straus, D. J., Testa, M. A., Von Roenn, J., Dezube, B. J., Cooley, T. P., Herndier, B., Northfelt, D. W., Huang, J., Tulpule, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706053362304 · Cited by 372
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., et al. (1997) · Blood · doi:10.1182/blood.v90.12.4710 · Cited by 332
Godwin, J. E., Kopecky, K. J., Head, D. R., Willman, C. L., Leith, C. P., Hynes, H. E., Balcerzak, S. P., & Appelbaum, F. R. (1998) · Blood · doi:10.1182/blood.v91.10.3607 · Cited by 312
Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322504 · Cited by 308
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
Crinò, L., Scagliotti, G., Marangolo, M., Figoli, F., Clerici, M., De Marinis, F., Salvati, F., Cruciani, G., Dogliotti, L., Pucci, F., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.297 · Cited by 303
Nichols, C. R., Williams, S. D., Loehrer, P. J., Greco, F. A., Crawford, E. D., Weetlaufer, J., Miller, M. E., Bartolucci, A., Schacter, L., & Einhorn, L. H. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1163 · Cited by 288
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
Rubenstein, E. B., Rolston, K., Escalante, C., Manzullo, E., Hughes, P., Fender, A., Elting, L., Bodey, G. P., Holmes, F., Loewy, J., et al. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3640::aid-cncr2820711128>3.0.co;2-h · Cited by 286
Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., et al. (2000) · Blood · doi:10.1182/blood.v95.5.1588.005k38_1588_1593 · Cited by 285
Larson, R. A., Dodge, R. K., LINKER, C. A., Stone, R. M., Powell, B. L., Lee, E. J., Schulman, P., Davey, F. R., Frankel, S. R., Bloomfield, C. D., et al. (1998) · PubMed · doi:10.1182/blood.v92.5.1556 · Cited by 269
Self-citationBeyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwaner, I., Oettle, H., Serke, S., Huhn, D., & Stieger, W. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1328 · Cited by 269
Grigg, A., Roberts, A., Raunow, H., Houghton, S., Layton, J., Boyd, A., McGrath, K., & Maher, D. (1995) · Blood · doi:10.1182/blood.v86.12.4437.bloodjournal86124437 · Cited by 264
Negrin, R., Haeuber, D., Nagler, A., Kobayashi, Y., Sklar, J., Donlon, T., Vincent, M., & Greenberg, P. (1990) · Blood · doi:10.1182/blood.v76.1.36.36 · Cited by 232
Talcott, J. A., Whalen, A., Clark, J., Rieker, P. P., & Finberg, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.107 · Cited by 230
Thatcher, N., Girling, D. J., Hopwood, P., Sambrook, R. J., Qian, W., Stephens, R. J., & for the Medical Research Council Lung Cancer Working Party (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.395 · Cited by 224
Löwenberg, B., Suciu, S., Archimbaud, E., Ossenkoppele, G. J., Verhoef, G. E. G., Vellenga, E., Wijermans, P., Berneman, Z. N., Dekker, A. W., Stryckmans, P. A., et al. (1997) · PubMed · doi:10.1182/blood.v90.8.2952 · Cited by 205
(1995) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(05)80058-6 · Cited by 197
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1957 · Cited by 197
Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., Sheridan, W. P., Kefford, R. F., Cebon, J., Olver, I., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00004 · Cited by 196
Bunn, P. A., Crowley, J., Kelly, K., Hazuka, M. B., Beasley, K., Upchurch, C., Livingston, R., Weiss, G. R., Hicks, W. J., & Gandara, D. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1632 · Cited by 190
Dillman, R., Davis, R., Green, M. R., Weiss, R. B., Gottlieb, A., Caplan, S. N., Kopel, S., Preisler, H., McIntyre, O. R., & Schiffer, C. A. (1991) · Blood · doi:10.1182/blood.v78.10.2520.2520 · Cited by 176
Self-citationKlumpp, T. R., Mangan, K. F., Goldberg, S. L., Pearlman, E. S., & Macdonald, J. S. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1323 · Cited by 176
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay, J., Chauvin, F., Cesne, A. L., Anglaret, B., Bouhour, D., Lasset, C., Freyer, G., Philip, T. O., & Biron, P. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.636 · Cited by 169
Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., MORISHIMA, Y., & Saito, Y. (1994) · Blood · doi:10.1182/blood.v83.8.2086.2086 · Cited by 153
Steward, W. P., von Pawel, J., Gatzemeier, U., Woll, P. J., Thatcher, N., Koschel, G., Clancy, L., Verweij, J., de Wit, R., Pfeifer, W., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.642 · Cited by 149
Witz, F., Sadoun, A., Perrin, M. C., Berthou, C., Brière, J., Cahn, J.-Y. Y., Lioure, B., Witz, B., François, S., Desablens, B., et al. (1998) · PubMed · doi:10.1182/blood.v91.8.2722.2722_2722_2730 · Cited by 146
Salmon, S. E., Crowley, J. J., Grogan, T. M., Finley, P. R., Pugh, R. P., & Barlogie, B. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2405 · Cited by 132
Löwenberg, B., Boogaerts, M. A., Daenen, S. M. G. J., Verhoef, G. E. G., Hagenbeek, A., Vellenga, E., Ossenkoppele, G. J., Huijgens, P. C., Verdonck, L. F., der Lelie, J. V., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.12.3496 · Cited by 126
Mayordomo, J. I., Rivera, F., Diaz-Puente, M., LIANES, P., Colomer, R., Lopez-brea, E., Paz-Ares, L. G., Hitt, R., Garcia‐Ribas, I., Cubedo, R., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.803 · Cited by 123
Zittoun, R., Suciu, S., Mandelli, F., de Witte, T., Thaler, J., Stryckmans, P. A., Hayat, M., Peetermans, M. E., Cadiou, M., Solbu, G., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2150 · Cited by 120
Mitchell, P. L., Morland, B. J., Stevens, M. C. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1163 · Cited by 113
Savarese, D. M. F., Hsieh, C., & Stewart, F. M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2981 · Cited by 106
Giralt, S. A., Escudier, S. M., Kantarjian, H. M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291103 · Cited by 97
Snowden, J. A., Biggs, J., Milliken, S., Fuller, A. K., Staniforth, D. H., Passuello, F., Renwick, J., & Brooks, P. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701486 · Cited by 96
Vellenga, E., Groot, C. A. U.-D., de Wit, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.619 · Cited by 96
Anaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95
Riikonen, P. V., Saarinen, U. M., Mäkipernaa, A., et al. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199403000-00006 · Cited by 94
Coia, L. R., Engstrom, P. F., & Paul, A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.11.1783 · Cited by 92
Weaver, C. H., Schulman, K. A., Wilson-Relyea, B. J., Birch, R., West, W. H., & Buckner, C. D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.43 · Cited by 85
Biesma, B., de Vries, E. G. E., Willemse, P. H. B., Sluiter, W. J., Postmus, P. E., Limburg, P. C., Stern, A. C., & Vellenga, E. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90613-x · Cited by 84
Hamm, J. T., Schiller, J. H., Cuffie, C., Oken, M. M., Fisher, R. I., Shepherd, F. A., & Kaiser, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2667 · Cited by 57
Ravaud, A., Chevreau, C., Cany, L., Houyau, P., Dohollou, N., Roche, H. H., Soubeyran, P., Bonichon, F., Mihura, J., Eghbali, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2930 · Cited by 51
Management of Infection in Patients with Acute Leukemia
Wade, J. C. (1993) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30268-5 · Cited by 35
Self-citation
Cited by
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationTomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Self-citation
Metadata
- Authors
- Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., Wade, J. L., Winn, R. J., Wozniak, A. J., Somerfield, M. R., & for the American Society of Clinical Oncology Growth Factors Expert Panel
- Venue
- Journal of Clinical Oncology
- Published
- 2000-10-20
- Volume
- 18
- Issue
- 20
- Pages
- 3558-3585
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2226490553
- Cited by
- 1,044
- References
- 75
- FWCI
- 33.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.